You are here: Industry Insights > Cancer

News List

Avesthagen study may help determine genetic predictors for tobacco-related cancers expresspharma
July 09, 2020
Researchers are studying about how Zoroastrian-Parsi genes may help scientists characterize biomarkers predictive of diseases caused by tobacco use, such as lung, head and neck, and esophagus cancers.
Partnership gets £4.4m gov grant for better liver diagnostics pharmatimes
July 03, 2020
Perspectum has been awarded a multimillion pound UK government research grant (UKRI) with partners for the development of new technology to help save patients’ lives by diagnosing liver disease earlier.
CR UK calls on Scottish gov to 'urgently' restart cancer trials pharmatimes
June 30, 2020
As of this morning – Tuesday June 30 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 311,965 with 43,575 deaths.
Common cancer treatments do not worsen COVID-19 infection, study finds europeanpharmaceuticalreview
June 30, 2020
A study has found that chemotherapy and surgery do not correlate with worse COVID-19 outcomes for cancer patients, whereas taking immune checkpoint inhibitors does.
FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials worldpharmanews
June 29, 2020
The U.S. Food and Drug Administration launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE).
Research charities warn of funding cuts in coronavirus wake pharmatimes
June 24, 2020
Charities including Cancer Research UK (CR UK) and the British Heart Foundation are warning that research funding will take a substantial hit in the wake of COVID-19 and that this will likely have significant consequences on survival.
Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines pharmaceutical-business-review
June 23, 2020
Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations.
Researchers develop highly sensitive blood test for cancer pharmatimes
June 22, 2020
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
NHS accelerates launch of new radiotherapy pharmatimes
June 16, 2020
NHS England is accelerating the launch of a new type of radiotherapy that requires fewer doses than current approaches, thus cutting the number of hospital visits for potentially vulnerable cancer patients.
AbbVie inks $750m cancer therapeutics deal with Genmab pharmaceutical-technology
June 15, 2020
AbbVie has entered a collaboration agreement with biotechnology company Genmab to develop and commercialise antibody therapeutics for cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page